Today

Agents

Chat

Arena

Discover

More

App

MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million - MDXG News | Rallies

MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million

MDXG•2026-07-29

Second-quarter results and outlook

Jul. 29 (Reuters) - MiMedx Q2 gross profit was USD 44.381 million.

Q2 adjusted EBITDA: USD -8.121 million vs. IBES estimate USD 2.06 million
Q2 net income: USD -14.84 million
Q2 operating income: USD -18.466 million
FY sales outlook: USD 260 million to USD 290 million vs. IBES estimate USD 269.4 million

Related News

Live Oak Bancshares director David G. Lucht sells 3,000 shares worth $126,396.3

LOB•2026-07-29

Insperity Q2 revenue and adjusted EPS beat estimates

NSP•2026-07-29

Everest Q2 FY26 net income falls 17.79% to USD 559 million; revenue drops 11.8% to USD 3.96 billion

•

2026-07-29

HCA Healthcare doubles commercial paper program limit to $8 billion

HCA•2026-07-29

Broadstone Net Lease Q2 EPS beats estimates, raises FY AFFO outlook

BNL•2026-07-29